Revolutionizing Therapeutic Drug Monitoring with the Use of Interstitial Fluid and Microneedles Technology
Open Access
- 11 October 2017
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 9 (4), 43
- https://doi.org/10.3390/pharmaceutics9040043
Abstract
While therapeutic drug monitoring (TDM) that uses blood as the biological matrix is the traditional gold standard, this practice may be impossible, impractical, or unethical for some patient populations (e.g., elderly, pediatric, anemic) and those with fragile veins. In the context of finding an alternative biological matrix for TDM, this manuscript will provide a qualitative review on: (1) the principles of TDM; (2) alternative matrices for TDM; (3) current evidence supporting the use of interstitial fluid (ISF) for TDM in clinical models; (4) the use of microneedle technologies, which is potentially minimally invasive and pain-free, for the collection of ISF; and (5) future directions. The current state of knowledge on the use of ISF for TDM in humans is still limited. A thorough literature review indicates that only a few drug classes have been investigated (i.e., anti-infectives, anticonvulsants, and miscellaneous other agents). Studies have successfully demonstrated techniques for ISF extraction from the skin but have failed to demonstrate commercial feasibility of ISF extraction followed by analysis of its content outside the ISF-collecting microneedle device. In contrast, microneedle-integrated biosensors built to extract ISF and perform the biomolecule analysis on-device, with a key feature of not needing to transfer ISF to a separate instrument, have yielded promising results that need to be validated in pre-clinical and clinical studies. The most promising applications for microneedle-integrated biosensors is continuous monitoring of biomolecules from the skin’s ISF. Conducting TDM using ISF is at the stage where its clinical utility should be investigated. Based on the advancements described in the current review, the immediate future direction for this area of research is to establish the suitability of using ISF for TDM in human models for drugs that have been found suitable in pre-clinical experiments.This publication has 88 references indexed in Scilit:
- Does Olanzapine Warrant Clinical Pharmacokinetic Monitoring in Schizophrenia?Clinical Pharmacokinetics, 2011
- Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis studyCancer Chemotherapy and Pharmacology, 2010
- Application of prolonged microdialysis sampling in carboplatin-treated cancer patientsCancer Chemotherapy and Pharmacology, 2008
- Application of Basic Pharmacokinetic Concepts to Analysis of Microdialysis DataClinical Pharmacokinetics, 2008
- Does Oxcarbazepine Warrant Therapeutic Drug Monitoring?Clinical Pharmacokinetics, 2008
- Impaired Target Site Penetration of Vancomycin in Diabetic Patients following Cardiac SurgeryAntimicrobial Agents and Chemotherapy, 2006
- SirolimusClinical Pharmacokinetics, 2005
- Clinical Pharmacokinetics in the 21st CenturyClinical Pharmacokinetics, 1998
- Drug Monitoring in Nonconventional Biological Fluids and MatricesClinical Pharmacokinetics, 1996
- Drug distribution studies with microdialysis III: Extracellular concentration of caffeine in adipose tissue in manLife Sciences, 1991